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OBJECTIVES The objective of the study was to investigate the impact of alteration of glycogen stores and
metabolism on exercise performance in patients with heart failure.
BACKGROUND In normal subjects, muscle glycogen depletion results in increased exertional fatigue and
reduced endurance. Skeletal muscle biopsies have revealed reduced glycogen content in
patients with congestive heart failure (CHF). Whether glycogen depletion contributes to
reduced endurance and abnormal ventilation in these patients is unknown.
METHODS Bicycle exercise tests with measurement of respiratory gases were performed following dietary
manipulations to induce glycogen depletion (60% protein, 40% fat) and slow glycogen
utilization (60% carbohydrate, 30% fat, 10% protein) in 13 patients with CHF (left
ventricular ejection fraction 22 6 6%; age 48 6 9 years) and 7 control subjects (age 45 6 5
years). Maximal exercise, exercise at 75% of peak workload until exhaustion and 1-min cycles
of supramaximal exercise at 133% of peak were performed on three occasions over a two-week
period.
RESULTS Significant changes in resting respiratory quotients (RQs) in normal (Baseline: 0.78 6 0.03;
Depleted: 0.69 6 0.05) and CHF subjects (Baseline: 0.84 6 0.05; Depleted: 0.72 6 0.05)
were observed (both p , 0.05). Peak VO2 (oxygen consumption) in both groups was
unchanged. The ventilatory response to exercise was analyzed by correlating CO2 production
(VCO2) to minute ventilation (VE) in each test. The slopes of these correlations were not
affected in either group. With glycogen depletion, exercise endurance was reduced from 17 to
6.1 min (57 6 19%) in normal subjects versus a reduction of 9.4 to 8.1 min (11 6 19%) in
patients (p , 0.05). With slowed glycogen use, CHF patients increased exercise endurance
from 9.4 to 16.5 min (65%) versus 17 to 20.6 min (18%) in normal subjects (p , 0.05).
CONCLUSIONS Glycogen depletion minimally affects maximal exercise performance, endurance or ventilation
in CHF patients, whereas slowed glycogen utilization markedly enhances exercise endurance.
Therapeutic interventions that increase or slow use of glycogen stores may have clinical
benefit. (J Am Coll Cardiol 1999;34:1807–12) © 1999 by the American College of
Cardiology
Glycogen provides a ready source of energy for use during
exercise (1,2). Glycogen stores are located primarily in the
liver and skeletal muscle. Breakdown of glycogen in the liver
frees glucose into the bloodstream. Glycogen breakdown in
the muscle yields only phosphorylated glucose, which is a
nondiffusable molecule and thus remains within the muscle
cell as a captured source of energy.
The rate-limiting enzyme for glycogen breakdown is
phosphorylase. This enzyme is activated by elevations in
intracellular levels of cyclic adenosine monophosphate
(cAMP), calcium and phosphate. Thus, catecholamines and
muscle contraction stimulate breakdown of glycogen. The
end product of glycogen metabolism is pyruvate, which can
be metabolized both anaerobically and aerobically. Pyruvate
can be converted in the cytosol to lactate by glycolysis or in
the mitochondria to CO2 (carbon dioxide) and water via the
Krebs cycle. Elevation of free fatty acids slows glycogen
utilization by increasing levels of acetyl CoA (coenzyme A)
and citrate, thereby inhibiting pyruvate dehydrogenase. This
negative feedback inhibition leads to an increase in glucose-
6-phosphate, which inhibits phosphorylase and slows gly-
cogen breakdown (Fig. 1).
During rest, cells derive most of their fuel from substrates
present in blood. During exercise, fuel combustion is deter-
mined by the intensity and duration of exercise as well as by
substrate availability. In the first few minutes of exercise,
muscle glycogen is the main fuel used to generate adenosine
triphosphate (ATP). This is followed by blood glucose and,
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during sustained exercise, by free fatty acids. Muscles rely
heavily on glycogen during heavy exercise owing to its
proximity.
Glycogen stores and metabolism in normal subjects affect
exercise endurance (3–5). Whether abnormalities in glyco-
gen metabolism contribute to reduced endurance in patients
with heart failure has not been studied. However, abnor-
malities in glycogen metabolism have been described in
heart failure. In a rat infarct model of congestive heart
failure (CHF), Musch and colleagues (6,7) described accel-
erated rates of glycogen breakdown and utilization in the leg
muscles of infarct rats versus sham controls. Biopsies of limb
skeletal muscle in patients with CHF have demonstrated
reduced glycogen levels (8). In vivo 31phosphorus magnetic
resonance spectroscopy also suggests an increased rate of
glycogenolysis in patients with CHF (9). Possible mecha-
nisms of abnormal glycogen metabolism in patients with
CHF include reduced delivery of substrates due to reduction
in skeletal muscle perfusion; elevated hormonal levels such
as catecholamines, which will increase breakdown of glyco-
gen; and intrinsic alteration of skeletal muscle metabolism
with an increased reliance on glycolytic activity. Decondi-
tioning also results in a greater reliance on carbohydrate
metabolism.
The purpose of this study was to investigate the effect of
glycogen depletion and slowed glycogen use on exercise
performance in patients with CHF. We hypothesized that,
in patients with CHF, glycogen depletion would minimally
affect exercise performance, whereas carbohydrate loading
with slowed glycogen utilization would enhance perfor-
mance.
METHODS
Subjects. Seven normal subjects and 13 patients with CHF
were studied (Table 1). The subjects were age-matched.
Five of the patients had coronary artery disease, and eight
patients had dilated cardiomyopathy. Mean ejection fraction
was 21% and peak VO2 (oxygen consumption) averaged 14
ml/kg/min. The majority of the patients had class II or III
CHF. None of the patients were being treated with beta-
blockers. None were diabetic. All had undergone prior
exercise testing with measurement of VO2. None of the
subjects were limited by chest pain or claudication. The
average age of the four men and three women who formed
the control group was 45 6 5 years. None of the normal
subjects were on any medications. All had normal history
and physical exams.
The protocol was approved by Columbia University’s
Committee on Studies Involving Human Beings. Written
informed consent was obtained from all subjects.
Exercise protocol. The exercise protocol consisted of three
parts—maximal, submaximal and supramaximal bicycle ex-
ercise. Sixty-minute rest periods separated the studies.
Before exercise, respiratory gases were collected for approx-
imately 10 min to measure basal respiratory quotient.
Routine bicycle exercise was then performed using 25-W
increments to peak exercise. Submaximal exercise consisted
of bicycling at 75% of peak workload until exhaustion. The
duration of exercise was recorded. Supramaximal exercise
consisted of 1 min of exercise at 133% of peak workload for
1 min followed by 2 min of rest. This was repeated until the
subject was unable to complete a full minute of exercise. The
number of full cycles was recorded.
The three-part exercise protocol was performed by the
patient in the fasting state on the afternoon of day 1. On
discharge to home, subjects were provided with a nutritional
drink consisting of 60% protein and 40% fat. Caloric
Abbreviations and Acronyms
ATP 5 adenosine triphosphate
BSA 5 body surface area
cAMP 5 cyclic adenosine monophosphate
CHF 5 congestive heart failure
CO2 5 carbon dioxide
RQ 5 respiratory quotient
VO2 5 oxygen consumption
Figure 1. Glycogen metabolism in muscle; asterisk denotes rate-
limiting enzyme.
Table 1. Clinical Characteristics of CHF Subjects
Etiology of CHF
Coronary artery disease 5
Cardiomyopathy 8
Age (yrs) 48 6 8
Gender
Men 11
Women 2
Ejection fraction (%) 21 6 6
Peak VO2 (ml/kg/min) 13.7 6 3
New York Heart Association classification
Class I 1
Class II 6
Class III 6
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content was determined by the subject’s body surface area
(BSA). Approximately 1,000 calories were provided. This
nutritional drink was the only food the subjects were
permitted. On day 2, patients again reported in the fasting
state, and the exercise protocol was repeated.
The following week, a nutritional drink was delivered the
night prior to exercise. It consisted of 60% carbohydrate,
30% protein, and 10% fat. Caloric content was again
determined from BSA and averaged 1,600 calories. The
next morning the subjects reported to the exercise lab where
a high-fat breakfast was served. Three and one-half hours
later, 2,000 U of heparin IV was administered to activate
lipoprotein lipase and thus increase formation of free fatty
acids. Thirty minutes later the exercise was repeated.
Breath assays. Peroxidation of fatty acids results in in-
creased production of alkanes, which can be measured in the
breath. Alkane breath concentrations were compared in
three patients in the fasting state following normal diet,
with glycogen depletion, and after carbohydrate loading.
Samples of alveolar breath and unfiltered room air (10
liter/min) were collected sequentially using a transportable
apparatus that captured the volatile organic compounds on
an adsorptive trap containing activated carbon and molec-
ular sieve as described previously by Phillips (10,11). The
volatile organic compounds were subsequently desorbed
from the absorptive trap in a microprocessor-controlled
thermal desorber and concentrated by two-stage cryofocus-
ing in sequential cold traps at 2150°C. The concentrated
sample was then separated by gas chromatography and
analyzed by mass spectroscopy with an ion-trap detector.
An alveolar gradient was calculated as the difference of
concentration in breath minus the concentration in inspired
air. A positive gradient was consistent with a metabolite
manufactured in the body. A negative gradient was consis-
tent with ingestion of an air pollutant. Positive gradients for
alkanes were recorded.
Statistical analysis. Statistical analysis was performed us-
ing t tests, analysis of variance (ANOVA) or chi-square
analysis for continuous and noncontinuous variables as
appropriate. Linear regression analysis was used to correlate
ventilation to CO2 production. As the design for the study
was a two-factor experiment (group and diet) with diet
treated as a repeated measure (i.e., multiple measurements
[within person] on the same unit), a repeated measures
ANOVA was utilized, including a test for interaction effects
(group 3 diet). Because of correlations within subject, F
tests were adjusted for their degrees of freedom, via univar-
iate methodology, including the estimation of the correla-
tion structure (i.e., compound symmetry, autoregressive
[AR(1)], unstructured, others), or by the more conservative
multivariate methods. Hence, p values were generated by
the most appropriate methods according to the assumptions
of repeated-methods ANOVA. Unless otherwise indicated,
p values were not adjusted for multiplicity of testing. Data
were analyzed using SAS system software (SAS Institute,
Cary, North Carolina).
RESULTS
Efficacy of dietary and exercise intervention. Resting
respiratory quotients and production of exhaled breath
alkanes were used to assess the effectiveness of our diet and
exercise interventions in shifting substrate utilization. Rest-
ing respiratory quotient (RQ) based exclusively on metab-
olism of 1 g of fat is approximately 0.71. Exclusive carbo-
hydrate metabolism would yield a resting RQ of 1.00.
Resting RQs for normal subjects and CHF subjects at
baseline, with glycogen depletion and with slowed glycogen
utilization demonstrated significant differences (Table 2). In
the glycogen-depleted state, both groups had significantly
reduced RQs. This shift in RQ reflects a greater reliance on
fat than on carbohydrate metabolism. Similarly, after the
high-carbohydrate diet, RQs tended to be higher than the
baseline values (Fig. 2).
Positive alveolar gradients for ethane (5.8 pmol/liter) and
decane (0.84 pmol/liter) were present in the three patients
following glycogen depletion but not in the baseline or
carbohydrate-loaded state. Positive alveolar gradients for
pentane production were seen in the control (0.4 pmol/liter)
and glycogen-depleted (0.39 pmol/liter) states. Exhaled
urea, probably representing protein metabolism, was ob-
served only in the glycogen-depleted state (0.16 pmol/liter).
Exercise performance. Peak VO2 measured at baseline,
during glycogen depletion, and with slowed glycogen utili-
zation was unchanged in both normal and CHF subjects
(Table 2). Peak VO2 was significantly lower in CHF subjects
than in normal subjects (Fig. 3).
Exercise duration during submaximal exercise was used as
a parameter of endurance. In normal subjects, glycogen
Table 2. Exercise Variables Measured in the Baseline, Glycogen-Depleted and Carbohydrate-Loaded States
Normal Subjects CHF Patients
RQ
Rest
RQ
Exercise
Peak VO2
(ml/kg/min)
VE/VCO2
1 liter
RQ
Rest
RQ
Exercise
Peak VO2
(ml/kg/min)
VE/VCO2
1 liter
Baseline 0.78 6 0.03 1.09 6 0.06 31.1 6 5.6 29.6 6 2.9 0.84 6 0.05 1.2 6 0.12 13.7 6 3.0 38 6 6
Depleted 0.69 6 0.05* 1.0 6 0.04* 29.5 6 6.3 32.0 6 2.7 0.72 6 0.05* 1.1 6 0.11* 13.9 6 3.1 39.8 6 6
Slowed use 0.86 6 0.06* 1.13 6 0.04 30.9 6 5.3 30.4 6 2.9 0.87 6 0.05 1.2 6 0.19 15.2 6 3.4 38 6 7
*p , 0.05 baseline versus depleted versus slowed use.
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depletion resulted in a significant deterioration of perfor-
mance, with a decrease in exercise time from 17 to 6 min
(57% decline) (p 5 0.02). With slowed glycogen utilization
there was a slight tendency to increase exercise time from 17
to 20.5 min (18% increase) (p 5 0.1). In contrast, glycogen
depletion minimally affected endurance in patients with
CHF. Exercise time was decreased from 9.4 to 8.1 min
(11% decline) (p 5 0.07). However, slowed glycogen
utilization significantly increased exercise duration, with
exercise time increasing 9.4 to 16.5 min (65% increase) (p 5
0.006) (Table 3, Fig. 4A).
With supramaximal exercise, during glycogen depletion
normal subjects had a significant deterioration in the num-
ber of cycles that could be completed, from 5 to 2 (p 5
0.003). Slowed glycogen utilization did not affect exercise
performance, as the number of completed cycles was un-
changed from baseline. In contrast, no significant change
from baseline was observed during glycogen depletion in
patients with CHF (6 vs. 5) (p 5 0.17), whereas the number
of cycles tended to increase during slowed utilization (6 vs.
8) (p 5 0.005) (Table 3, Fig. 4B).
Ventilation. The ventilatory response to exercise was as-
sessed by performing a linear regression of minute ventila-
tion to CO2 production and solving the equation for the
ventilation at a VCO2 of 1 liter. No significant change in
ventilation was observed in either group with dietary ma-
nipulations (Table 2).
Subjective assessment of exercise intensity. When the
intensity of exercise was compared to the baseline studies, all
normal subjects felt that, during glycogen depletion, the
exercise was much more difficult. In contrast, 11 of 13 CHF
patients noted the exercise to be either of the same intensity
or easier. With slowed glycogen utilization, both groups
found the exercise to be the same or easier, although a larger
percentage of patients felt exercise intensity was reduced
(Table 4).
DISCUSSION
This study demonstrates that, contrary to the normal
response, glycogen depletion does not affect exercise endur-
ance in patients with CHF, whereas alteration of diet to
slow glycogen utilization significantly enhances exercise
endurance in these patients.
Measurement of basal RQs in normal and CHF subjects
demonstrated the adequacy of our dietary interventions and
Figure 3. Peak VO2 in the normal and CHF groups in the basal,
glycogen-depleted, and slowed glycogen-utilization states.
Figure 2. Histogram of basal respiratory quotients in normal and
CHF subjects with a normal diet, following carbohydrate-poor and
-rich diets.
Figure 4. (A) Exercise duration during submaximal exercise in
normal and CHF groups. (B) Number of completed cycles during
supramaximal exercise in the normal and CHF groups.
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exercise protocol in producing glycogen depletion. In both
groups, RQ was significantly lower than baseline values,
suggesting a shift from carbohydrate to free fatty acid
metabolism. Moreover, volatile alkanes measured in the
breath of CHF patients were increased in the glycogen-
depleted state. This is consistent with increased per-
oxidation of free fatty acids (1).
In normal subjects, glycogen depletion did not affect
maximal VO2 but significantly diminished exercise endur-
ance. Subjectively, with glycogen depletion, normal subjects
uniformly experienced tremendous fatigue and an increased
difficulty in performing exercise. Slowed glycogen utiliza-
tion tended to increase exercise endurance. The observed
changes are consistent with prior reports (3–5).
In CHF subjects, alteration of glycogen metabolism did
not affect peak VO2. However, in contrast to normal
subjects, glycogen depletion had minimal effect on exercise
endurance. Only 2 of the 13 CHF patients experienced
fatigue with glycogen depletion. The majority sensed no
difference between the basal and glycogen-depleted states.
Further depletion of an already depleted state appears to
minimally affect exercise endurance in these patients. Alter-
native explanations would include inability to use glycogen
stores or the inadequacy of our protocol to deplete glycogen
stores in these patients owing to the low exercise workloads
used. The reduction in basal RQ and increased production
of volatile alkanes would support a shift of metabolism from
carbohydrate to free fatty acid, and thus the efficacy of our
protocol to induce glycogen depletion in this patient pop-
ulation. Direct measurement of glycogen in muscle biopsies
preceding each exercise protocol would have directly an-
swered these questions.
Patients with CHF have an excessive ventilatory response
to exercise. Glycogen depletion has variably been shown to
increase ventilation in normal subjects (12). The mechanism
for increased ventilation may be neurogenic, resulting from
an increase in muscle fiber recruitment, as glycogen-
depleted muscle fibers cannot maintain adequate tension at
high power outputs. In our study, alteration of glycogen
metabolism did not affect the ventilatory response to exer-
cise in either normal subjects or CHF patients. As the
changes observed in prior studies tended to be small, the
absence of changes in this population may be related to the
small number of subjects and/or differences in our data
analysis.
Slowed utilization of glycogen stores following carbohy-
drate loading resulted in an impressive increase in exercise
endurance in CHF subjects. Subjectively, exercise was noted
by most patients to be easier. Correction of a depleted state
versus less rapid use of glycogen stores or both may have
resulted in these findings. Earlier studies have suggested an
accelerated rate of glycogen breakdown and utilization in
heart failure (6,7,9). Moreover, insulin resistance has been
described in patients with CHF (13,14). Insulin resistance
would impair glucose uptake, resulting in a greater reliance
on glycogen metabolism with more rapid depletion of this
substrate. Thus, nutritional interventions that replete and/or
slow breakdown of glycogen could be beneficial for these
patients.
In several studies, aerobic training has been shown to
improve endurance in patients with CHF (15,16). Exercise-
induced enzymatic changes in lipid metabolism lead to an
increase in the supply and metabolism of free fatty acids.
This shift from carbohydrate metabolism results in dimin-
ished glycogen use and increased muscle glycogen content.
The improvement in endurance observed with training may
in part be related to changes in glycogen content. Kemp et
al. (9) demonstrated a reduction in glycogen phosphorylase
activation following aerobic training in patients with CHF.
Study limitations. The major limitation of the study is the
noninvasive techniques used to assess the adequacy of our
diet and exercise protocol. We did not measure glycogen
content in percutaneous muscle biopsies owing to the
invasiveness of this procedure and need to do repeated
biopsies in a short time frame.
Table 3. Exercise Performance During Submaximal and Supramaximal Exercise in the Normal
and HFC Groups
Submaximal Exercise (min) Supramaximal Exercise (n)
Normal CHF Normal CHF
Baseline 17.0 6 4.8 9.4 6 4 4.6 6 0.8 6.2 6 2.6
Depleted 6.1 6 1.9* 8.1 6 3.1 1.9 6 1.0* 5.0 6 1.6
Slowed use 20.5 6 8.5 16.5 6 5.6* 5.1 6 1.0 7.8 6 2.8*
*p , 0.05 baseline versus depleted versus slowed use.
Table 4. Subjective Assessment of Exercise Difficulty
Normal CHF
Glycogen Depleted*
Harder 7 2
Easier 0 5
Same 0 6
Slowed Utilization*
Harder 0 0
Easier 4 9
Same 3 4
*p , 0.05. Normal subjects versus CHF patients.
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Clinical implications. The ability to sustain submaximal
work is critical to daily functioning and quality of life.
Fatigue remains a disabling symptom in CHF. Therapeutic
interventions that can improve endurance and reduce fa-
tigue are important to the quality of life of these patients.
Our study suggests that therapeutic interventions and/or
simple dietary modifications that slow glycogen utilization,
increase glycogen stores, or shift substrate utilization from
carbohydrate to free fatty acids may increase endurance and
alleviate fatigue in patients with CHF. To quote Marie
Antionette: “Let them eat cake.”
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